)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
HBM Holdings (2142) investor relations material
HBM Holdings H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary27 Aug, 2025
Executive summary
Achieved revenue of US$101.3 million and net profit of US$73.0 million for H1 2025, a significant increase from US$23.7 million revenue and US$1.4 million profit year-over-year.
Major global collaborations established with AstraZeneca, Otsuka, and Windward Bio, securing substantial upfront, milestone payments, and equity investments.
Advanced multiple clinical and preclinical programs in immunology, oncology, metabolic, and CNS diseases, with BLA acceptance for Batoclimab and new IND approvals.
Financial highlights
Revenue rose 327.5% year-over-year to US$101.3 million for H1 2025, mainly from molecule license fees (US$93.7 million) and research & technology license fees (US$7.6 million).
Net profit surged to US$73.0 million from US$1.4 million in H1 2024.
R&D costs increased to US$18.0 million, reflecting expanded clinical and discovery activities.
Cash and cash equivalents reached US$320.7 million as of June 30, 2025, up from US$166.8 million at year-end 2024.
Basic and diluted EPS were US$0.09, up from US$0.00 year-over-year.
Outlook and guidance
Confident in continued portfolio expansion and value realization through global partnerships, with plans to accelerate clinical trials and expand into immunology and inflammation.
Focus on optimizing discovery efficiency and expanding global collaboration networks.
AstraZeneca equity investment rationale?
Metabolic/CNS disease strategy evolution?
Shift in R&D cost allocation drivers?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next HBM Holdings earnings date
H2 202530 Mar, 2026
Next HBM Holdings earnings date
H2 202530 Mar, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
HBM Holdings Limited is a China-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative antibody therapeutics. The company utilizes its proprietary antibody technology platforms to develop a pipeline of monoclonal antibodies targeting various diseases, including cancer and autoimmune disorders. HBM Holdings conducts research and clinical development independently and through strategic partnerships in both domestic and international markets. The company is headquartered in Shanghai, China, and its shares are listed on the HKEX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage